Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Virun® Making an Impact at PGA Show January 2020
Virun® will be amongst the 1,000+ interactive exhibitors attending the PGA Merchandise Show in Orlando, Florida January 21 through January 24. - December 06, 2019 - VIRUN
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Equator Pure Nature CEO Peter Wainman Named “Expat Entrepreneur of the Year for Corporate Social Responsibility” in Thailand in 2019
Peter N. Wainman, the founder and CEO of Bangkok-based Equator Pure Nature Co., Ltd., was named the “Expat Entrepreneur of the Year for Corporate Social Responsibility” at the Thailand International Business Awards 2019. The award, presented in conjunction with the British Chamber of... - December 02, 2019 - Equator Pure Nature Co., Ltd.
CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference
CLL Society co-founder and Medical Director Dr. Brian Koffman will present research results of the society's innovative telemedicine program at the prestigious American Society of Hematology annual meeting in early December. The program provides patients and caregivers access to HIPPA-compliant second opinions from renowned specialists in chronic lymphocytic leukemia (CLL), the most common adult blood cancer. - November 30, 2019 - CLL Society
Northern Optotronics Inc.'s New Dedicated Business Unit Helps U.S. and International Companies Resolve the Difficulty in Providing Repair Service Across Canada
Northern Optotronics Inc. (NOI), today announced the launch of its dedicated business unit focused on customized service and repair solutions across Canada for manufacturers and providers of medical equipment, aesthetic, surgical, and industrial lasers. - November 29, 2019 - NOI
JOGO Health to Launch 30 Digital Therapeutics Clinics in Malaysia to Treat Stroke, Pain and Incontinence
The clinics will use the award winning technology developed by two pioneering scientists in the USA that has also been shown to treat 17 other neuromuscular diseases. - November 28, 2019 - JOGO Health Inc.
New York Imaging Specialists Announces Grand Opening in Port Jefferson Station
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776. New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes... - November 28, 2019 - New York Imaging Specialists
Dr. Varghese Cherian Joins New York Imaging Specialists
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton. Dr. - November 28, 2019 - New York Imaging Specialists
Good News: a Panel of TGF-Beta and TGF-Beta Receptor Antibodies is Created by Abbomax
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
Mavericks Renewable Energy and San Benito Hemp Campus Team Up to Create the First Carbon Negative Microgrid
San Benito Hemp Campus has over 300,000 square feet of seed production, secure storage, curing, processing and hemp facility in San Benito County, California. Opening in 2020, San Benito Hemp Campus will be the largest vertically integrated hemp processing facility in the United States. San Benito... - November 22, 2019 - Mavericks Renewable Energy
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019 - ALS Therapy Development Institute
Nuriv® Delivers Impressive Lineup of Patented CBD Formulations
Nuriv® releases patented CBD formulations: RELAX, SLEEP, JOINT, along with its stand-alone CBD products, Hazelnut, Chocolate Brownie and French Vanilla. These release a powerfull Micellized form of CBD in amazing flavors, such as Peanut Butter Cup and Chocolate Brownie. Micellized compounds that are water insoluble absorb quicker, half speedy onset and improved Pharmacokinetics. 20mg CBD per 10ml serving and 22 servings per 8oz. - November 20, 2019 - VIRUN
Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announced
SMi Reports: the agenda and speaker overview of the upcoming SMi 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view. - November 07, 2019 - SAE Media Group
Academy Medical Announces That Their Vendor Partner, RenovoDerm Has Been Added to Their DoD DAPA Contract
Academy Medical announces that their vendor partner, RenovoDerm has been added to their DoD DAPA contract. Through Academy Medical’s contract, RenovoDerm will market their Phoenix Wound Matrix and Rotium Bioresorbable Wick products to DoD medical facilities. - November 06, 2019 - Academy Medical
NuvOx Pharma US Patent Issuance - Radiotherapy and Chemotherapy with an Oxygen Therapeutic
NuvOx Pharma, Inc, a clinical stage biopharmaceutical company developing NanO2TM emulsion for oxygen delivery today announced the issuance of US Patent 10,456,468 – Fractionated Radiotherapy and Chemotherapy with an Oxygen Therapeutic. NanO2TM emulsion is designed to increase tumor oxygen... - November 03, 2019 - NuvOx Pharma
Varicose Veins Doctors Now Offers Non-Intrusive Varicose Vein Treatments
Varicose Veins Doctors is a trusted vein treatment clinic in Manhattan, NY. The clinic has made a name for itself by offering exceptional patient care and a selection of effective treatment options for vein diseases. Their teams of experts use state-of-the-art equipment to perform complex procedures for pain relief. - October 25, 2019 - Varicose Veins Doctors
Tom Murphy Joins Bench International as VP of Business Development and Executive Recruitment
In a move that benefits life science companies throughout the San Diego area, Bench International has hired Tom Murphy as its new Vice President of Business Development and Executive Recruitment. Murphy, who led the business development program at CONNECT, a top innovation company accelerator in... - October 24, 2019 - Bench International
Alicia Kali, Founder and CEO of Pancea Biomed and Purpose DRVN Joins the Ultimate Sports Network for Part Two of Their Concussion Discussion
Continuing the concussion discussion with Alicia Kali, CEO of Panacea Biomed and Purpose DRVN, and Ultimate Sports Networks' host Frank Gordon. - October 18, 2019 - Ultimate Sports Networks Unlimited, LLC.
Aciont Issued Key Patent Covering the Novel Design of the Visulex Ocular Drug Delivery Device
Aciont was issued a U.S. patent that covers an important aspect of the novel design of its main Visulex ocular drug delivery system which has been tested for safety and efficacy in its lead clinical program under U.S. IND. - October 12, 2019 - Aciont Inc.
BÜHLMANN Laboratories AG Receives FDA Clearance for CALEX® Cap Fecal Calprotectin Extraction Device
BÜHLMANN CALEX® Cap, a single use tube intended for the preparation of human stool samples to be used with the BÜHLMANN fCAL® turbo, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - September 25, 2019 - BUHLMANN Diagnostics Corp
Cayman Awarded 1.5 Million Dollar SBIR Grant
The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company
A Year After the Launch of Ayushman Bharat Yojana; Medical Devices, Pharma Industries in India Expected to Benefit Substantially: Whitepaper by Nexdigm (SKP)
In 2017, the Indian Government introduced a National Health Policy (Ayushman Bharat or Healthy India) that aims to offer universal health coverage and provide the foundation for equitable healthcare. In this paper, SKP examines the potential of the NHPS and attempts to study the impact it creates on healthcare accessibility along with opportunities created for various stakeholders in the industry. - September 22, 2019 - Nexdigm
CloudLIMS’ New Training Module Continues Commitment to Supporting ISO/IEC 17025 Accreditation
CloudLIMS releases a new training module continues commitment to supporting ISO 17025 ISO/IEC 17025 accreditation. - September 20, 2019 - CloudLIMS
Oncoheroes Biosciences Inc. and Boehringer Ingelheim International GmbH Sign Exclusive Licensing Agreement for Volasertib
Oncoheroes Biosciences Inc (“Oncoheroes”) and Boehringer Ingelheim International GmbH (“Boehringer Ingelheim”) have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered and developed by... - September 19, 2019 - Oncoheroes Biosciences Inc.
DNAtix Launches Free Anonymous Genetic Vault
Digital DNAtix Ltd., the Israeli cyber genetics startup, has announced the first free anonymous genetic vault service. DNAtix developed the Cyber Genetics Smart Platform for Digital Genetics. Lack of privacy is currently a barrier for so many people who want to have their DNA tested but are afraid to give their genetic data away. As of today anyone can anonymously upload their raw file from 23&Me and Ancestry.com onto the DNAtix platform. - September 17, 2019 - Digital DNAtix Ltd.
NRHI Hosts 3rd Annual National Affordability Summit in Minneapolis
Dr. Marty Makary, Susan Dentzer and more are joining NRHI on October 15-16 to discuss critical issues impacting today’s healthcare landscape. - September 12, 2019 - Network for Regional Healthcare Improvement
Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Protein
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
Bench International to Grow Life Science Companies in San Diego
The city of San Diego has all the components to become a global R&D hub, and Bench International is announcing its footprint and commitment to make a direct impact by building the hub’s position on the global life science stage. Effective Sept. 1, Bench International has become embedded... - September 05, 2019 - Bench International
RapidBac™Vet Combating Antimicrobial Resistance in Veterinary Care
RapidBac™Vet is a 17-minute, in-house test for bacteria in urine. For use on both dogs and cats. RapidBac™Vet has been validated in clinical studies comparing RapidBac™Vet test results to gold-standard urine culture with >97% accuracy at one-third the cost of a urine culture. - August 29, 2019 - RapidBac™Vet
ABA Publishing Releases New Book, "The Law of Artificial Intelligence and Smart Machines," Co-Authored by Attorney and Industry Expert, Eric Boughman from ForsterBoughman
ABA Publishing has released a new book, "The Law of Artificial Intelligence and Smart Machines: Understanding AI and the Legal Impact," co-authored by attorney and industry expert, Eric Boughman from the law firm of ForsterBoughman. It examines the legal implications of artificial intelligence and discusses a wide-range of topics including healthcare regulation, data and privacy concerns, cybernetics and bio-robotics, copyright law, cybersecurity issues, and the practice of transactional law. - August 22, 2019 - Forster Boughman Lefkowitz & Lowe
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC
Arteric Named a Top 100 Healthcare Marketing Agency by MM&M
Latest accolade follows a year of 30% revenue growth and thought leadership. - August 09, 2019 - Arteric
Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism
Thrombolex, Inc. today announced the enrollment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir™ Endovascular Catheter for the treatment of submassive pulmonary embolism (PE). The device was designed to quickly and safely dissolve thrombus and... - July 29, 2019 - Thrombolex, Inc.
Hedgepath, LLC Files Lawsuit Alleging Self-Dealing in Hedgepath Pharmaceuticals, Inc. by Its Controlling Stockholder
Lawsuit alleges self-dealing in Hedgepath Pharmaceuticals, Inc. by its controlling stockholder, an indirect subsidiary of Mayne Pharma Group Ltd. with estimated damages exceeding $800,000,000. - July 23, 2019 - Hedgepath LLC
Rubix LS Enters Into an Agreement to Support Infectious Disease Data Research
Rubix LS will collaborate with the United Nations, Global Health Policy Advocates and many more on an opportunity to collect data geared with leaping toward prevention of infectious diseases. - July 20, 2019 - Rubix LS
Current and Future Freeze-Drying Technologies and Methods
Optima to host post-conference workshop at Lyophilization USA. - July 07, 2019 - SAE Media Group
Tigerlily Foundation Hosts Historic Young Women’s Metastatic Breast Cancer Disparities Listening Summit
Tigerlily Foundation is leading the charge to make an impact on MBC related concerns and young women of color, by hosting the first ever Metastatic Breast Cancer Disparities Listening Summit on March 20, 2019. This unique forum gave young women of color a platform that was different from the norm - they voiced their needs as the experts, while industry, healthcare and policymakers listened. - June 28, 2019 - Tigerlily Foundation
BÜHLMANN Laboratories AG Receives FDA Clearance for Its fCAL® turbo Automated, Random Access Calprotectin Test
BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - June 27, 2019 - BUHLMANN Diagnostics Corp
Virtus Group, LLC Announces Partnership with Betts Consulting
Virtus Group, LLC announces its partnership with Betts Consulting. The resulting alliance offers 40 years of experience in Pre-Clinical, as well as Phases I-IV of Clinical Development Services. Adding expertise in the CMC, CMC Regulatory Affairs, Project Management, and Finished Products area. - June 27, 2019 - Virtus Group, LLC
BioSource Cultures and Flavors is Now 100 % Owned by Suresh Family
BioSource Cultures & Flavors, a primary manufacturer of lactic cultures and flavors located in Muskego, Wisconsin, has recently been purchased in 100% equity by its President and Founder, Dr. Narayan Suresh. - June 25, 2019 - BioSource Cultures and Flavors
Hans Kaspersetz Shares Arteric's Approaches to Leveraging Artificial Intelligence in Healthcare Marketing at Digital Pharma West
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result - June 23, 2019 - Arteric
Multiplex ELISAs Offer Powerful Profiling Capabilities
Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. - June 22, 2019 - Cayman Chemical Company
Orangetheory Fitness and Augie’s Quest Collaboration Funds Innovative Research at the ALS Therapy Development
This past May over 1,100 members of Orangetheory Fitness ran, rowed, and lifted, earning “splat points,” which they turned into $4.5 million in donations for Augie’s Quest to Cure ALS. With this donation Augie’s Quest is supporting non-profit biotech, the ALS Therapy Development Institute (ALS TDI), to fast track cure-driven drugs for ALS. - June 20, 2019 - ALS Therapy Development Institute
The OMEGATOF, a Fully Integrated Benchtop Spectrometer Instrument for High-Mass MALDI Applications with the Power of CovalX Technology Inside
CovalX has partnered with Shimadzu Scientific Instruments to offer the OMEGATOF, an integrated MALDI solution for ultra high-mass detection. With a focus on the detection of large molecules, including biotherapeutics, protein complexes, aggregates, and antibody-antigen interactions in a benchtop... - June 13, 2019 - CovalX
Corey Dambacher, Ph.D. Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication
Corey Dambacher, Ph.D. of La Jolla, California has been recognized as a Professional of the Year for 2019 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the field of biotechnology consulting. About Corey Dambacher With over 20 years... - June 12, 2019 - Strathmore Worldwide
Ingredient Alliance Announces Launch of Pharma Grade CBN/CBG/THCV and Early Harvest Biomass
Designer Cannabinoids take center stage at Ingredient Alliance. - June 11, 2019 - Ingredient Alliance
Matreya, LLC is Now a Part of Cayman Chemical Company to Better Serve the Lipid Community
Cayman Chemical, an industry-leading supplier of bioactive lipids, analytical standards, and contract lipidomic services, announced today that it has acquired Matreya, LLC, a lipid biochemical company located in State College, Pennsylvania, with strengths in synthesis, extraction, and purification of natural products. Matreya stocks a wide selection of high-purity sphingolipids, phospholipids, fatty acids and esters, and sterols to be used as research standards. - June 05, 2019 - Cayman Chemical Company
Pillar Clinical Research Announces New Ratings Initiative: Pillar Precision
The Dallas based research company plans to roll out a new clinical rating training program, Pillar Precision. The program includes a clinician guide featuring best practices for specific CNS indications, placebo response training, malingering detection, data-driven decision making, and multi-site... - May 24, 2019 - Pillar Clinical Research
Apostle Inc. Completes Series A Financing Led by ShangBay Capital
Apostle Inc. is pleased to announce the completion of its series A financing, raising $3.3 million. The investment round is led by ShangBay Capital, a Silicon Valley-based venture capital firm, focused on investing in early stage medical device and biotech companies. Three other Silicon... - May 24, 2019 - Apostle Inc